Chemoinformaics analysis of BREVIFOLIN-CARBOXYLIC-ACID-10-MONOSULPHATE
| Molecular Weight | 372.263 | nRot | 3 |
| Heavy Atom Molecular Weight | 364.199 | nRig | 19 |
| Exact Molecular Weight | 371.979 | nRing | 3 |
| Solubility: LogS | -3.88 | nHRing | 1 |
| Solubility: LogP | -0.645 | No. of Aliphatic Rings | 1 |
| Acid Count | 2 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 1 |
| nHetero | 12 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 10 |
| No. of Oxygen atom | 11 | No. of Arom Bond | 11 |
| nHA | 9 | APOL | 38.7663 |
| nHD | 4 | BPOL | 20.7577 |
| QED | 0.335 |
| Synth | 3.779 |
| Natural Product Likeliness | 1.103 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.007 |
| HIA | 0.567 |
| CACO-2 | -5.767 |
| MDCK | 0.0000242 |
| BBB | 0.002 |
| PPB | 0.929009 |
| VDSS | 0.503 |
| FU | 0.0746857 |
| CYP1A2-inh | 0.046 |
| CYP1A2-sub | 0.059 |
| CYP2c19-inh | 0.025 |
| CYP2c19-sub | 0.033 |
| CYP2c9-inh | 0.085 |
| CYP2c9-sub | 0.033 |
| CYP2d6-inh | 0.001 |
| CYP2d6-sub | 0.058 |
| CYP3a4-inh | 0.006 |
| CYP3a4-sub | 0.004 |
| CL | 0.88 |
| T12 | 0.597 |
| hERG | 0 |
| Ames | 0.007 |
| ROA | 0.101 |
| SkinSen | 0.512 |
| Carcinogencity | 0.136 |
| EI | 0.131 |
| Respiratory | 0.84 |
| NR-Aromatase | 0.001 |
| Antiviral | Yes |
| Prediction | 0.66721 |